FDA label 430669d7-9ad2-9a04-e063-6394a90ababb

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
33881d79-9b8b-f9dc-e063-6394a90aba81
SPL ID
430669d7-9ad2-9a04-e063-6394a90ababb
Version
4
Effective date
2025-11-07
Source export date
2026-09-28
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:37:54

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS Patients with hypocalcemia (such as uremia) are prone to numbness, pain, twitching, dyspnea and other symptoms after correcting acidosis, which are often caused by the decrease of calcium ion concentration in the blood; Accelerated heart rate, chest tightness, shortness of breath and other pulmonary edema, heart failure; Elevated blood pressure; Weight gain, edema; Alkalosis occurs when overdose; The concentration of blood potassium decreases, and sometimes hypokalemia appears.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.